Free Trial

Agape ATP (ATPC) Competitors

Agape ATP logo
$1.45 +0.26 (+21.85%)
(As of 12/20/2024 05:31 PM ET)

ATPC vs. MRAI, PMD, TOI, BRTX, OPGN, KDLY, OTRK, MGRX, VSEE, and BGLC

Should you be buying Agape ATP stock or one of its competitors? The main competitors of Agape ATP include Marpai (MRAI), Psychemedics (PMD), Oncology Institute (TOI), BioRestorative Therapies (BRTX), OpGen (OPGN), Kindly MD (KDLY), Ontrak (OTRK), Mangoceuticals (MGRX), Vsee Health (VSEE), and BioNexus Gene Lab (BGLC). These companies are all part of the "healthcare" industry.

Agape ATP vs.

Agape ATP (NASDAQ:ATPC) and Marpai (NASDAQ:MRAI) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, media sentiment, valuation, profitability, dividends, community ranking and institutional ownership.

0.0% of Agape ATP shares are held by institutional investors. Comparatively, 49.8% of Marpai shares are held by institutional investors. 61.3% of Marpai shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Agape ATP has a beta of 2.21, indicating that its stock price is 121% more volatile than the S&P 500. Comparatively, Marpai has a beta of 4.93, indicating that its stock price is 393% more volatile than the S&P 500.

Marpai has a net margin of -85.70% compared to Agape ATP's net margin of -194.09%. Marpai's return on equity of 0.00% beat Agape ATP's return on equity.

Company Net Margins Return on Equity Return on Assets
Agape ATP-194.09% -74.71% -56.08%
Marpai -85.70%N/A -100.23%

Marpai has a consensus price target of $6.00, indicating a potential upside of 510.69%. Given Marpai's stronger consensus rating and higher probable upside, analysts plainly believe Marpai is more favorable than Agape ATP.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Agape ATP
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Marpai
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Marpai received 2 more outperform votes than Agape ATP when rated by MarketBeat users.

CompanyUnderperformOutperform
Agape ATPN/AN/A
MarpaiOutperform Votes
2
66.67%
Underperform Votes
1
33.33%

In the previous week, Agape ATP's average media sentiment score of 0.00 equaled Marpai'saverage media sentiment score.

Company Overall Sentiment
Agape ATP Neutral
Marpai Neutral

Agape ATP has higher earnings, but lower revenue than Marpai. Agape ATP is trading at a lower price-to-earnings ratio than Marpai, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Agape ATP$1.35M4.27-$2.10M-$0.73-1.99
Marpai$37.15M0.36-$28.75M-$2.64-0.37

Summary

Marpai beats Agape ATP on 11 of the 15 factors compared between the two stocks.

Get Agape ATP News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATPC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ATPC vs. The Competition

MetricAgape ATPHealth services IndustryMedical SectorNASDAQ Exchange
Market Cap$5.78M$867.07M$5.12B$9.07B
Dividend YieldN/A1.90%4.91%4.22%
P/E Ratio-1.9932.2091.3417.19
Price / Sales4.273.751,117.70116.80
Price / CashN/A25.1442.6437.86
Price / Book1.272.924.794.78
Net Income-$2.10M-$5.79M$120.07M$225.60M
7 Day Performance1.40%-4.93%-1.90%-1.23%
1 Month Performance-4.61%-4.89%11.45%3.37%
1 Year Performance-89.18%226.77%30.63%16.58%

Agape ATP Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATPC
Agape ATP
N/A$1.45
+21.8%
N/A-88.5%$5.78M$1.35M-1.9940Positive News
Gap Down
MRAI
Marpai
N/A$1.20
-4.0%
$6.00
+400.0%
-47.7%$16.49M$34.87M-0.42150Gap Down
PMD
Psychemedics
1.3983 of 5 stars
$2.67
-1.8%
N/A-5.3%$15.73M$22.10M-5.24140Insider Trade
Gap Down
High Trading Volume
TOI
Oncology Institute
2.5303 of 5 stars
$0.20
-11.7%
$2.50
+1,170.3%
-88.1%$14.87M$378.93M-0.29660
BRTX
BioRestorative Therapies
3.455 of 5 stars
$1.46
+0.7%
$18.00
+1,132.9%
-11.4%$10.10M$150,000.00-0.917
OPGN
OpGen
N/A$1.07
-3.6%
N/A-82.8%$8.95M$3.42M0.00100Analyst Forecast
News Coverage
Gap Down
KDLY
Kindly MD
N/A$1.15
-11.5%
N/AN/A$6.87M$2.88M0.00N/AGap Down
OTRK
Ontrak
2.6188 of 5 stars
$1.57
-4.3%
$45.00
+2,766.2%
-76.2%$6.62M$11.24M-0.15250Positive News
MGRX
Mangoceuticals
1.1854 of 5 stars
$2.53
-3.1%
N/A-96.2%$6.29M$755,000.00-0.453News Coverage
Gap Up
VSEE
Vsee Health
N/A$1.31
-12.1%
N/AN/A$4.72M$6.38M0.00N/ANews Coverage
Gap Down
BGLC
BioNexus Gene Lab
N/A$0.26
-0.5%
N/A-61.5%$4.65M$9.26M0.0030Gap Up

Related Companies and Tools


This page (NASDAQ:ATPC) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners